Is AOD-9604 Legal in Virginia?
At a glance
- FDA approval / None. Never approved as a drug [1][2]
- FDA safety view / Possible immunogenicity risk, limited safety data, serious adverse events of unclear cause [6]
- FDA compounding categories / Not in any category for pharmacies, physicians, or outsourcing facilities [3][4][5]
- Approved dose / None [2]
- Sport / Banned at all times by WADA [7]
- What it is / A 16-amino-acid fragment of growth hormone [8]
What FDA's lists say about AOD-9604
AOD-9604 was developed by an Australian company, Metabolic Pharmaceuticals, as an obesity drug candidate; phase IIa trials were under way by February 2002, it never reached approval, and the obesity program was later dropped [1][2]. Chemically it is growth hormone amino acids 177 to 191 with an extra tyrosine at the front — 16 amino acids, not full-length growth hormone [8]. A 2026 review reports that the main human obesity study, which tested an oral drug candidate, did not show a significant benefit on its primary weight-loss endpoint [2].
FDA's page on bulk substances that may present significant safety risks lists AOD-9604 in the table of nominations withdrawn by the nominator, which is where substances previously placed in category 2 ended up [6]. FDA's stated concerns: compounded drugs containing AOD-9604 may pose significant immunogenicity risk for certain routes of administration related to peptide impurities and characterization problems; FDA has identified no, or only limited, safety information; and 'FDA has also identified serious adverse events that may be associated with AOD-9604, though causality is not clear' [6]. Removal from category 2 was not a finding that it is safe [6].
FDA does not list AOD-9604 in any category for state-licensed pharmacies and physicians, and it does not appear on FDA's outsourcing-facility list [3][4][5]. Compounded drugs are not FDA-approved, and FDA does not review their safety, effectiveness, or quality before they reach patients [9].
Is AOD-9604 in the new federal peptide policy?
No. HHS filed a draft enforcement-discretion policy for compounded peptides on October 28, 2026 covering six peptides — BPC-157, epitalon, KPV, MOTS-c, Semax and TB-500 — and AOD-9604 is not one of them [10][11]. It was also not on the agenda of FDA's July 23-24, 2026 Pharmacy Compounding Advisory Committee meeting, which took up BPC-157, KPV, TB-500, MOTS-c, emideltide, Semax and epitalon [12].
Is AOD-9604 'GRAS'?
FDA's GRAS Notice Inventory has no AOD-9604 entry; searches of the inventory for 'AOD9604', 'AOD', 'growth hormone' and 'peptide' on October 29, 2026 returned nothing [13]. GRAS concerns intended uses of substances added to food and is not an FDA drug approval [14].
Is it banned in sport?
WADA's Prohibited List names AOD-9604 and hGH 176-191 in S2.2.3 (growth hormone fragments), prohibited at all times, in and out of competition; S2 substances are non-Specified Substances [7]. It is on the 2026 List, in force since January 1, 2026, and stays on the 2027 List [15]. Anti-doping scientists have published a urine detection method for AOD-9604 and a stable metabolite [8].
Frequently asked questions
Is AOD-9604 legal in Virginia?
Does removal from FDA's category 2 list mean AOD-9604 is now allowed?
Is AOD-9604 the same as human growth hormone?
Is AOD-9604 banned in sport?
References
- Wilding J. AOD-9604 Metabolic. Curr Opin Investig Drugs. 2004;5(4):436-40. AOD-9604 Metabolic
- Dominikowski A, Rękoś Z, Olejarz M, Szczepanek-Parulska E, Domin R, RuchaŁa M. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. Front Endocrinol (Lausanne). 2026;17:1822475. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration
- U.S. Food and Drug Administration. U.S. Food and Drug Administration
- U.S. Food and Drug Administration. U.S. Food and Drug Administration
- Bulk Drug Substances Used in Compounding of the FD&C Act | FDA. Bulk Drug Substances Used in Compounding of the FD&C Act | FDA
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA
- World Anti-Doping Agency. World Anti-Doping Agency
- Cox HD, Smeal SJ, Hughes CM, Cox JE, Eichner D. Detection and in vitro metabolism of AOD9604. Drug Test Anal. 2015;7(1):31-8. Detection and in vitro metabolism of AOD9604
- Human Drug Compounding Laws | FDA. Human Drug Compounding Laws | FDA
- Official web page. Official web page
- Official web page. Official web page
- U.S. Food and Drug Administration. U.S. Food and Drug Administration
- GRAS Notices. GRAS Notices
- Generally Recognized as Safe (GRAS) | FDA. Generally Recognized as Safe (GRAS) | FDA
- World Anti-Doping Agency. World Anti-Doping Agency